accretive: dilutive 101, page-3

xanax...this looks exactly the same as mashala purchase except worth less!
If it was the first dilution it would be one thing. However the dilution of shareholders equity that has gone on just leaves all shareholders feeling like they have been betrayed and foolish to boot. Shareholder trust has been betrayed here. Lies have been told.
Then we get another dodgy purchase. We are told no details. What consulting fees have been to whom and when?
Now you expect us long term shareholders to like it??????
We've had enough!